[18F]-T807 PET/CT Imaging of Tau Pathology in Young Onset Focal Dementia

Trial Profile

[18F]-T807 PET/CT Imaging of Tau Pathology in Young Onset Focal Dementia

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 04 Apr 2017

At a glance

  • Drugs Flortaucipir-F-18 (Primary)
  • Indications Alzheimer's disease; Dementia; Primary progressive aphasia
  • Focus Diagnostic use
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 29 Mar 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Dec 2017.
    • 11 Jan 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top